Noor Shaker

Noor Shaker is a Syrian British entrepreneur and computer scientist specializing in the application of artificial intelligence to drug discovery and medical diagnostics. She is the founder and CEO of SpatialX, a company applying AI to pathology to improve cancer diagnostics. Previously, she co-founded the AI for drug discovery start-up Glamorous AI. Glamorous AI was acquired by the US-based company X-Chem in Nov 2021. Before Glamorous AI, Noor founded the drug discovery start-up GTN Ltd and was CEO for more than two years. In 2018, she received a CogX UK Rising Star Award from Prime Minister Theresa May for "AI technology that will transform drug discovery to treat chronic diseases".